Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Marcel Lucas de AlmeidaLaboratório de Desenvolvimento Galênico, Farmácia Universitária, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0002-1603-8391
Ana Paula Dos Santos MatosInstitute of Drug Technology-Farmanguinhos, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-2691-5335
Veronica da Silva CardosoLaboratório de Biotecnologia BIOINOVAR (Unidade de Biocatálise, Bioprodutos e Bioenergia), Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0001-9456-7558
Tatielle do NascimentoLaboratório de Desenvolvimento Galênico, Farmácia Universitária, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.
Ralph Santos-OliveiraLaboratory of Nanoradiopharmacy and Synthesis of Novel Radiopharmaceuticals, Nuclear Engineering Institute, Rio de Janeiro 21941-598, Brazil.ORCID 0000-0002-0905-481X
Leandro Machado RochaLaboratório de Tecnologia de Produtos Naturais, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro 24210-201, Brazil.ORCID 0000-0003-0484-1918
Francisco Paiva MachadoLaboratório de Tecnologia de Produtos Naturais, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro 24210-201, Brazil.ORCID 0000-0002-5332-9972
Franklin Chimaobi KenechukwuDrug Delivery and Nanomedicines Research Group, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria, Enugu 410105, Nigeria.ORCID 0000-0002-1619-4474
Alane Beatriz VermelhoLaboratório de Biotecnologia BIOINOVAR (Unidade de Biocatálise, Bioprodutos e Bioenergia), Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0001-5926-4172
Eduardo Ricci-JúniorLaboratório de Desenvolvimento Galênico, Farmácia Universitária, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro 21941-901, Brazil.ORCID 0000-0002-2550-696X
Funding
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, FAPERJ E-26/200.278/2024Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, FAPERJ E-26/200.279/2024Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, FAPERJ E-26/203.921/2024National Council for Scientific and Technological Development (CNPq) 309790/2023-9
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections. · full record | OpenQuestion